Literature DB >> 25131045

Acute kidney injury after liver transplantation: incidence and mortality.

F Klaus1, C Keitel da Silva2, G Meinerz2, L M Carvalho3, J C Goldani2, G Cantisani4, M L Zanotelli4, V Duro Garcia5, E Keitel2.   

Abstract

INTRODUCTION: Patients undergoing orthotopic liver transplantation often present with acute kidney injury (AKI) in the postoperative period. It has been associated with a greater number of complications and high mortality rates. The goal of this study was to determine the incidence of AKI during the early posttransplant period and mortality in patients undergoing orthotopic liver transplantation in our hospital. PATIENTS AND METHODS: In this retrospective cohort study, we reviewed the medical records of all patients aged >18 years undergoing liver transplantation from April 2008 to April 2011. The exclusion criteria were a glomerular filtration rate (estimated by using the Modification of Diet in Renal Disease formula) <60 mL/min/1.73 m(2) or AKI at the time of transplantation. AKI was defined as an increase ≥50% from preoperative baseline serum creatinine levels during the hospitalization period.
RESULTS: Of 113 selected patients, 78 (69%) were male. The mean age was 54.03 ± 9.38 years. The mean preoperative baseline creatinine level was 0.94 ± 0.15 mg/dL, and the estimated glomerular filtration rate was 87.09 ± 19.67 mL/min/1.73 m(2). The mean calculated Model for End-Stage Liver Disease score was 13. Hepatitis C serology was present in 70.8%, hepatitis B in 11.5%, hepatocellular carcinoma in 75.2%, and alcohol abuse in 31.9% of patients. The incidence of AKI was 56.6% (64 of 113 patients). The main risk factors for AKI were Model for End-Stage Liver Disease score and diuretic use at baseline. Renal replacement therapy (RRT) was performed in 19.5% (22 of 113) of patients. The hospital mortality rate in the group with AKI was 25% (16 of 64 patients) and 6.1% (3 of 49 patients) between patients without AKI (odds ratio, 5.11 [confidence interval, 1.39-18.7]; P < .01]. Among patients who underwent RRT, the in-hospital mortality rate was 54.5% (12 of 22 patients) compared with 7.7% (7 of 91 patients) from the other remaining patient cohort (odds ratio, 14.40 [confidence interval, 4.60-45.00]; P < .01).
CONCLUSIONS: There was a high incidence of AKI in patients undergoing liver transplantation and an increased risk of mortality among patients who needed RRT.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25131045     DOI: 10.1016/j.transproceed.2014.05.053

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  18 in total

1.  Hemodynamics and vasoactive substance levels during renal congestion that occurs in the anhepatic phase of liver transplantation.

Authors:  Zhong-Xin Li; Man-Cai Wang; You-Cheng Zhang; Jie Mao; Mo Chen; Rui Ni; Feng-Xian Wei; Gen-Nian Wang; Ling-Yi Zhang
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

2.  Incidence and outcomes of acute kidney injury in patients with hepatocellular carcinoma after liver transplantation.

Authors:  Xiaohong Chen; Xiaoqiang Ding; Bo Shen; Jie Teng; Jianzhou Zou; Ting Wang; Jian Zhou; Nan Chen; Boheng Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-13       Impact factor: 4.553

Review 3.  Renal Hemodynamics, Function, and Oxygenation in Critically Ill Patients and after Major Surgery.

Authors:  Sven-Erik Ricksten; Gudrun Bragadottir; Lukas Lannemyr; Bengt Redfors; Jenny Skytte
Journal:  Kidney360       Date:  2021-03-03

Review 4.  Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.

Authors:  J Levitsky; J G O'Leary; S Asrani; P Sharma; J Fung; A Wiseman; C U Niemann
Journal:  Am J Transplant       Date:  2016-04-22       Impact factor: 8.086

5.  Acute kidney injury after pediatric liver transplantation: incidence, risk factors, and association with outcome.

Authors:  Miho Hamada; Shino Matsukawa; Satoshi Shimizu; Shinichi Kai; Toshiyuki Mizota
Journal:  J Anesth       Date:  2017-08-01       Impact factor: 2.078

6.  Ulinastatin ameliorates acute kidney injury following liver transplantation in rats and humans.

Authors:  Xiaoyun Li; Xiang Li; Xinjin Chi; Gangjian Luo; Dongdong Yuan; Guoliang Sun; Ziqing Hei
Journal:  Exp Ther Med       Date:  2014-11-25       Impact factor: 2.447

Review 7.  Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective.

Authors:  Rodolfo Castro; Hugo Perazzo; Beatriz Grinsztejn; Valdilea G Veloso; Chris Hyde
Journal:  Int J Hepatol       Date:  2015-11-29

8.  Successful Anti-HCV Therapy of a Former Intravenous Drug User with Sofosbuvir and Daclatasvir in a Peritranspant Setting: A Case Report.

Authors:  Leon Louis Seifert; Hauke Heinzow; Iyad Kabar; Stefan Christensen; Anna Hüsing; Hartmut H-J Schmidt
Journal:  Am J Case Rep       Date:  2016-08-24

9.  Renal function and oxygenation are impaired early after liver transplantation despite hyperdynamic systemic circulation.

Authors:  Jenny Skytte Larsson; Gudrun Bragadottir; Bengt Redfors; Sven-Erik Ricksten
Journal:  Crit Care       Date:  2017-04-11       Impact factor: 9.097

10.  Effects of hydroxyethyl starch and gelatin on the risk of acute kidney injury following orthotopic liver transplantation: A multicenter retrospective comparative clinical study.

Authors:  Yingqi Chen; Xinyu Ning; Haiyang Lu; Sainan Zhu; Anshi Wu; Jia Jiang; Shanshan Mu; Jing Wang; Xu Niu; Shengnan Li; Lingdi Hou; Yanxing Zhao; Wenfei Lv; Meixia Shang; Chen Yao; Shujun Han; Ping Chi; Fushan Xue; Yun Yue
Journal:  Open Med (Wars)       Date:  2021-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.